STAT3 and melanoma: Another preclinical study revealed that this agent lowers the growth of melanoma cell lines and induces mitochondrial apoptosis, which impairs cell migration and invasion, reduces expression of phosphorylated STAT3 at Tyr705, and inhibits matrix metalloproteinase-2 and -9 expression [104].